The Treatment Options and Clinical Significance of Immune Thrombocytopenia Patients with Splanchnic Vein Thrombosis as the Initial Manifestation / 中国实验血液学杂志
Journal of Experimental Hematology
;
(6): 887-892, 2021.
Article
in Chinese
| WPRIM
| ID: wpr-880164
ABSTRACT
OBJECTIVE@#To investigate the causes, treatment options and outcomes of immune thrombocytopenia (ITP) patients with splanchnic venous thrombosis (SVT).@*METHODS@#The clinical diagnosis, treatment and outcomes data of one 26-year-old male ITP patient with SVT as initial manifestation were collected. The possible causes and treatment options of the patients were discussed through literatures review.@*RESULTS@#The result of blood routine tests of the patient showed that Plt(17-38)×10@*CONCLUSION@#ITP combined with large scale of SVT is rare, and it is difficult to cure. It should be pay more attention to the possible thrombosis risk triggered by a transiently increased EOS in the blood stream. Promptly etiological treatment and the balance between anticoagulant therapy and bleeding risks should be taken in clinical practice.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Splanchnic Circulation
/
Purpura, Thrombocytopenic, Idiopathic
/
Heparin, Low-Molecular-Weight
/
Venous Thrombosis
/
Anticoagulants
Limits:
Aged
/
Aged80
/
Humans
/
Male
Language:
Chinese
Journal:
Journal of Experimental Hematology
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS